ASSESSMENT OF THYROID CANCER INCIDENCE IN KAZAKHSTAN
DOI:
https://doi.org/10.31082/1728-452X-2020-221-222-11-12-2-7Keywords:
thyroid cancer, incidence, KazakhstanAbstract
Thyroid cancer (TC) is the most wide spread malignant tumor of the endocrine glands. According to the International Agency for Research on Cancer, more than 586,200 new cases of TC were registered in the world in 2020. However spatial arrangement of this disease indicates a different distribution of this pathology all over the world.
The aim to assess the peculiarities of the incidence of TC in Kazakhstan.
Materials and methods. The study was retrospective – the study period was 10 years (20092018). The material for the study was data of new cases of TC. In the research were used descriptive and analytical methods of oncoepidemiology.
Results and discussion. We found out that the average age of patients with TC in women (51.8±0.2 years) were less than in men (53.2±0.5 years). The crude rate and standardized incidence rates in women (5.4±0.40/0000 and 5.1±0.370/0000, respectively) were higher than in men (0.9±0.10/0000 and 1.1±0.10/0000, respectively). Age-related indicators of the incidence of TC were characterized by a peak in 60-69 years – 4.21±0.200/0000 in men and 15.37±1.210/0000 in women. Trends in morbidity tended to increase in both women (Tg=+7.8%) and men (Tg=+5.0%).
Conclusion: Age and gender features of TC incidence were established in the whole country. The obtained data are recommended for use in planning anti-cancer activities.
References
Ferlay J, Ervik M, Lam F, Colombet M, et al. (2018). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/ today, accessed december 2, 2020
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019 Apr 15;144(8):941-1953. doi: 10.1002/ijc.31937
Vaccarella S, Franceschi S, Bray F, et al. Worldwide thyroid-cancer epidemic? N Engl J Med. 2016;375(7):614-617. doi:10.1056/NEJMp1604412.
Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646-653. doi: 10.1038/nrendo.2016.110
Fraser S, Zaidi N, Norlén O, et al. Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer. Ann Surg Oncol. 2016 Oct; 23(11):3587-3592. doi: 10.1245/ s10434-016-5254-8
Igissinov N, Kozhakhmetov S, Zhantubetova M, et al. Thyroid Cancer in Kazakhstan: Component Analysis of Incidence Dynamics. Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2875-2880. doi: 10.31557/ APJCP.2019.20.9.2875
Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212. doi: 10.1155/2013/965212
Rumyantseva UV, Rumyantsev PO, Ilyin AA. Clinical and genetic aspects of diagnosis and treatment of hereditary forms of medullary thyroid cancer. Problemy endokrinologii = Problems of Endocrinology. 2006;5(2):21-27. (In Russ.)
Cancer epidemiology: principles and methods/ Isabel dos Santos Silva. Lion, France: IARC, 1999
Primenenie metodov statisticheskogo analiza dlya izucheniya obshestvennogo zdorovya I zdrovoohraneniya [Application of statistical analysis methods for the study of public health and public health]. M: GEOTAR-MED; 2011:256
Toshiro Tango. Statistical Methods for Disease Clustering. Springer Science+Business Media, LLC; 2010:247
Merkov AM, Polyakov LE. Sanitarnaya statistika [Sanitary statistics]. Leningrad: Medicine; 1974:384
Omar B, Ahmad, Cynthia Boschi-Pinto, Alan D Lopez, et al. Age standardization of rates: a new who standard. GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization 2001. Available from: http://www.who.int/healthinfo/paper31.pdf. (accessed November 10, 2020)
Recommendations of the National Cancer Institute (USA) on the use of the World Standard (WHO 2000-2025). Available from: http://seer.cancer.gov/stdpopulations/world.who.html (accessed November 10, 2020)
